Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia L Mottram

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Immunology and Cell Biology|September 13, 2003
Past, present and future drug treatment for rheumatoid arthritis and systemic lupus erythematosusPatricia L Mottram
Immunology and Cell Biology|September 13, 2003
The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosusCaroline Tan Sardjono, Patricia L Mottram, P Mark Hogarth
Springer Seminars in Immunopathology|November 9, 2006
FcgammaRII and multi-system autoimmune diseaseNicholas C van de Velde, Patricia L Mottram, P Mark Hogarth
Vaccine|October 6, 2005
Systemic immune responses in sheep, induced by a novel nano-bead adjuvantJean-Pierre Y Scheerlinck, Simone Gloster, Anita Gamvrellis, et al.
Transplant Immunology|August 17, 2002
Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodiesPatricia L Mottram, Lisa J Murray-Segal, Wenruo Han, et al.
Methods (San Diego, Calif.)|September 26, 2006
Pathogen recognition and development of particulate vaccines: does size matter?Sue D Xiang, Anja Scholzen, Gabriela Minigo, et al.
Veterinary Immunology and Immunopathology|June 29, 2013
Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheepAnita Gamvrellis, Simone Gloster, Meryem Jefferies, et al.
Immunology Letters|December 17, 2009
Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cellsNicholas C Van de Velde, Patricia L Mottram, Maree S Powell, et al.
Methods (San Diego, Calif.)|September 26, 2006
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicityMartha Kalkanidis, Geoffrey A Pietersz, Sue D Xiang, et al.
Molecular Pharmaceutics|February 6, 2007
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virusPatricia L Mottram, David Leong, Blessing Crimeen-Irwin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Immunology and Cell Biology|September 13, 2003
Past, present and future drug treatment for rheumatoid arthritis and systemic lupus erythematosusPatricia L Mottram
Immunology and Cell Biology|September 13, 2003
The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosusCaroline Tan Sardjono, Patricia L Mottram, P Mark Hogarth
Springer Seminars in Immunopathology|November 9, 2006
FcgammaRII and multi-system autoimmune diseaseNicholas C van de Velde, Patricia L Mottram, P Mark Hogarth
Vaccine|October 6, 2005
Systemic immune responses in sheep, induced by a novel nano-bead adjuvantJean-Pierre Y Scheerlinck, Simone Gloster, Anita Gamvrellis, et al.
Transplant Immunology|August 17, 2002
Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodiesPatricia L Mottram, Lisa J Murray-Segal, Wenruo Han, et al.
Methods (San Diego, Calif.)|September 26, 2006
Pathogen recognition and development of particulate vaccines: does size matter?Sue D Xiang, Anja Scholzen, Gabriela Minigo, et al.
Veterinary Immunology and Immunopathology|June 29, 2013
Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheepAnita Gamvrellis, Simone Gloster, Meryem Jefferies, et al.
Immunology Letters|December 17, 2009
Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cellsNicholas C Van de Velde, Patricia L Mottram, Maree S Powell, et al.
Methods (San Diego, Calif.)|September 26, 2006
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicityMartha Kalkanidis, Geoffrey A Pietersz, Sue D Xiang, et al.
Molecular Pharmaceutics|February 6, 2007
Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virusPatricia L Mottram, David Leong, Blessing Crimeen-Irwin, et al.
Pageof 2